| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/20/2011 | US20110014723 Compositions and processes relating to human bocavirus |
| 01/20/2011 | US20110014710 Compositions, methods and kits for biarsenical fluorophore labeling |
| 01/20/2011 | US20110014676 Protein stabilization |
| 01/20/2011 | US20110014675 Poly zinc finger proteins with improved linkers |
| 01/20/2011 | US20110014635 Marker peptide for alzheimer's disease |
| 01/20/2011 | US20110014634 Nucleic acids encoding t2r, a novel family of taste receptors |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014627 Method for determining antagonist activity to a cytokinin receptor |
| 01/20/2011 | US20110014608 SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014341 Soybean variety a1016502 |
| 01/20/2011 | US20110014279 Bioactive complex compositions and methods of use thereof |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014242 Promoters for expression in modified vaccinia virus ankara |
| 01/20/2011 | US20110014238 Immunogenic protein pas n 1 from bahia grass pollen |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 01/20/2011 | US20110014209 Recombinant hcv e2 glycoprotein |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014182 Antigen binding proteins |
| 01/20/2011 | US20110014169 High affinity ny-eso t cell receptors |
| 01/20/2011 | US20110014152 Increased t-cell tumor infiltration and eradication of metastases by mutant light |
| 01/20/2011 | US20110012894 Crystal structure of the complex of hepatocyte growth factor beta chain with met receptor and methods of use |
| 01/20/2011 | US20110012096 Photoactive nanostructure and method of manufacturing same |
| 01/20/2011 | DE102009033281A1 New polypeptide, comprising amino acid sequences, useful for the diagnosis of paraneoplastic neurological syndromes, autoimmune diseases and/or cancer |
| 01/20/2011 | CA2768485A1 Treatment of infections |
| 01/20/2011 | CA2768343A1 Detoxified escherichia coli immunogens |
| 01/20/2011 | CA2768321A1 Microrna-24 |
| 01/20/2011 | CA2768186A1 Rsv f protein compositions and methods for making same |
| 01/20/2011 | CA2768149A1 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | CA2768082A1 Novel fatty acid desaturases and elongases and uses thereof |
| 01/20/2011 | CA2767972A1 Dual vector for inhibition of human immunodeficiency virus |
| 01/20/2011 | CA2767957A1 Regulation of zinc deficiency and tolerance in plants |
| 01/20/2011 | CA2767865A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| 01/20/2011 | CA2767860A1 Serum markers associated with early and other stages of breast cancer |
| 01/20/2011 | CA2767826A1 Mesenchymal stem cell differentiation using aniopoietin-like-3 |
| 01/20/2011 | CA2767792A1 Acylated glucagon analogues |
| 01/20/2011 | CA2767760A1 Process and system for obtaining botulinum neurotoxin |
| 01/20/2011 | CA2767755A1 Inhibitors of complement activation |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275814A1 A -oligomer measurement method |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275573A1 Antibodies for treating and diagnosing gastric adenocarcinoma |
| 01/19/2011 | EP2275572A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275571A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275570A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275562A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 01/19/2011 | EP2275559A2 Optimized messenger RNA |
| 01/19/2011 | EP2275558A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275556A1 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 01/19/2011 | EP2275554A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275553A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275552A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275551A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275545A1 Use of microRNA-24 and/or its targets for the treatment and prevention of ischemia and induction of angiogenesis |
| 01/19/2011 | EP2275544A2 Genes and polypeptides relating to human colon cancers |
| 01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
| 01/19/2011 | EP2275531A1 Method for proliferation of pluripotent stem cell |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275447A1 Methods of inhibiting metastasis |
| 01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |
| 01/19/2011 | EP2275442A1 Detection and vizualization of the cell cycle in living cells |
| 01/19/2011 | EP2275441A1 High affinity HIV T cell receptors |
| 01/19/2011 | EP2275440A2 Growth factor-mimicking peptides and uses thereof |
| 01/19/2011 | EP2275439A2 Novel insulin derivatives |
| 01/19/2011 | EP2275438A1 Glucagon-like peptide-2 analogs |
| 01/19/2011 | EP2275437A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 01/19/2011 | EP2275436A1 Fermentation of moderately thermophilic Bacilli on sucrose |
| 01/19/2011 | EP2275435A2 Streptococcus agalactiae antigens I + II |
| 01/19/2011 | EP2275434A1 Borrelia antigens |
| 01/19/2011 | EP2275432A1 Nanofiltration of factor VII solutions to remove virus |
| 01/19/2011 | EP2275131A2 HCV Vaccines |
| 01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
| 01/19/2011 | EP2274431A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/19/2011 | EP2274428A1 Isolated peptides having phospholipase inhibitory activity |
| 01/19/2011 | EP2274416A2 Commensal bacteria as signal mediators within a mammalian host |
| 01/19/2011 | EP2274331A1 Improved fibronectin-based binding molecules and uses thereof |
| 01/19/2011 | EP2274330A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/19/2011 | EP2274329A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/19/2011 | EP2274328A1 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/19/2011 | EP2274327A2 Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin |
| 01/19/2011 | EP2274326A1 Suppressor of the endogenous interferon- gamma |
| 01/19/2011 | EP2274325A1 Human g-csf analogs and methods of making and using thereof |
| 01/19/2011 | EP2274324A1 Substances and compositions for enhancing dna repair and methods of use |
| 01/19/2011 | EP2274323A1 Peptides for inhibiting the hpv-e6 oncoprotein |
| 01/19/2011 | EP2274322A1 Polypeptides having ferulic acid esterase activity and polynucleotides encoding same |
| 01/19/2011 | EP2274321A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases |
| 01/19/2011 | EP1940872B9 Peptides exhibiting efficacies of improvement in skin conditions or treatment of periodental diseases |
| 01/19/2011 | EP1905869B1 Three-dimensional structure of functional material |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1675969B1 Nitrite-oxidizing bacteria and methods of using and detecting the same |
| 01/19/2011 | EP1644501B1 Ssx-2 peptides presented by hla class ii molucules |
| 01/19/2011 | EP1606391B1 Virulent systemic feline calicivirus |
| 01/19/2011 | EP1600507B1 Mutant SREBP-1c promoters and use thereof |
| 01/19/2011 | EP1590663B1 Immunocompromised rodents as dual color tumor models |